Animal Models Of Liver Cirrhosis And Fibrosis

Authors

  • Rabani, Vahideh
  • Baharvand , Hossein
  • Farzaneh , Zahra
  • Pournasrkhakbaz, Behshad
Abstract:

Animal modeling is a crucial necessity in clinical studies of liver diseases. Authenticity of the data which are produced using this tool under different conditions and accuracy of the analyses and assessments which would be based on such data sets is completely dependent on the adoption of a standardized methodology for analyzes and assessment of these data sets. Cirrhosis and Fibrosis are among the most important diseases which are studied by animals modeling due to the fact that their final structure is usually similar among a verity of patients and also because they are the common end stage of most chronic liver diseases. Up to now, different approaches such as hepatotoxicity and surgical methods have been utilized to obtain cirrhotic or fibrotic models that either of which have its especial advantages and disadvantages. It is obvious that using models could indicate the production and treatment mechanisms of disease which we elucidate Fibrosis and cirrhosis here. Considering several animal models which were used for liver disease in the world, in this survey we try to explain why, what and how an animal must be choosen for modeling and how could be evaluated.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Endocrine-Manifestations of Cirrhosis and Liver Disease

The liver is involved in the synthesis and metabolism of many kinds of hormones, various abnormalities hormone levels are found in advanced liver disease. For example the liver is, extremely sensitive to changes in insulin or glucagon levels. The liver is the primary organ of iron storage is frequently involved, diabetes is common in patients with iron overload and may be seen in cirrhosis. Chr...

full text

Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.

Multiple organ systems, including the gastrointestinal tract, pancreas, and hepatobiliary systems, are affected by cystic fibrosis (CF). Many of these changes begin early in life and are difficult to study in young CF patients. Recent development of novel CF animal models has expanded opportunities in the field to better understand CF pathogenesis and evaluate traditional and innovative therape...

full text

Dysregulation of ENaC in Animal Models of Nephrotic Syndrome and Liver Cirrhosis

Nephrotic syndrome and liver cirrhosis are common clinical manifestations, and are associated with avid sodium retention leading to the development of edema and ascites. However, the mechanism for the sodium retention is still incompletely understood and the molecular basis remains undefined. We examined the changes of sodium (co)transporters and epithelial sodium channels (ENaCs) in the kidney...

full text

Histopathological evaluation of liver fibrosis and cirrhosis regression

The hepatic repair complex in the setting of cirrhosis has received increasing attention, as it implies the regression of cirrhosis, which was traditionally taken to be an irreversible state. In this brief review, the patterns of fibrosis, the existing staging systems for chronic liver disease and the histopathological features of cirrhosis regression are discussed.

full text

unani treatment decreased fibrosis and improved liver functions in decompensated cirrhosis of liver: a case series

at present, liver transplantation remains the only curative option for the patients with cirrhosis and end-stage liver diseases. the survival rate and recurrent diseases remain the major issues in the patient post-transplantation. unani medicine is one of the oldest traditional systems of medicine which has been treating chronic liver diseases and cirrhosis (talayyaful-kabid) for centuries. the...

full text

An adipocentric view of liver fibrosis and cirrhosis.

Liver fibrosis is the consequence of chronic or repeated liver injury caused by hepatotoxic agents like alcohol and viruses, as well as immune and congenital metabolic disorders. Nonalcoholic fatty liver disease (NAFLD), caused by obesity and abnormal lipid metabolism, may be the latest known cause of liver fibrosis and cirrhosis. Furthermore, NAFLD with obesity can provide a terrain in which a...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 28

pages  0- 0

publication date 2009-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023